Tansna Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Tansna Therapeutics General Information

Description

Developer of novel drugs intended to improve the lives of patients suffering from debilitating disorders. The company's novel drugs are safe, oral and anticonvulsant agents that effectively reduce seizure frequency in patients with epilepsy, enabling physicians to treat their patients in an enhanced way.

Contact Information

Website
www.tansna.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4320 Forest Park Avenue
  • Suite 303
  • Saint Louis, MO 63108
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 4320 Forest Park Avenue
  • Suite 303
  • Saint Louis, MO 63108
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tansna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Sep-2018 Completed Out of Business
4. Early Stage VC (Series A) 26-Feb-2014 Completed Generating Revenue
3. Seed Round 19-Feb-2013 Completed Generating Revenue
2. Grant 25-Oct-2012 $15K Completed Startup
1. Grant 01-Jan-2011 $181K Completed Startup
To view Tansna Therapeutics’s complete valuation and funding history, request access »

Tansna Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Tansna Therapeutics’s complete cap table history, request access »

Tansna Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel drugs intended to improve the lives of patients suffering from debilitating disorders. The company's
Drug Discovery
Saint Louis, MO

Cambridge, MA

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tansna Therapeutics Competitors (38)

One of Tansna Therapeutics’s 38 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Regenacy Pharmaceuticals Venture Capital-Backed Waltham, MA
Genentech Formerly VC-backed South San Francisco, CA
EyeD Pharma Venture Capital-Backed Seraing, Belgium
Orbsen Therapeutics Private Equity-Backed Galway, Ireland
You’re viewing 5 of 38 competitors. Get the full list »

Tansna Therapeutics Patents

Tansna Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016190871-A1 2,5-dialkyl-4-h/halo/ether-phenol compounds Inactive 28-May-2015
US-20150148430-A1 2,5-dialkyl-4-h/halo/ether-phenol compounds Active 22-Nov-2013
US-20170174600-A1 2,5-dialkyl-4-h/halo/ether-phenol compounds Inactive 22-Nov-2013
US-9630896-B2 2,5-dialkyl-4-h/halo/ether-phenol compounds Inactive 22-Nov-2013 C07C39/06

Tansna Therapeutics FAQs

  • When was Tansna Therapeutics founded?

    Tansna Therapeutics was founded in 2010.

  • Where is Tansna Therapeutics headquartered?

    Tansna Therapeutics is headquartered in Saint Louis, MO.

  • What industry is Tansna Therapeutics in?

    Tansna Therapeutics’s primary industry is Drug Discovery.

  • Is Tansna Therapeutics a private or public company?

    Tansna Therapeutics is a Private company.

  • What is Tansna Therapeutics’s current revenue?

    The current revenue for Tansna Therapeutics is .

  • How much funding has Tansna Therapeutics raised over time?

    Tansna Therapeutics has raised $949K.

  • Who are Tansna Therapeutics’s competitors?

    AnTolRx, Regenacy Pharmaceuticals, Genentech, EyeD Pharma, and Orbsen Therapeutics are some of the 38 competitors of Tansna Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process